Table 2.
Relationship between adipose tissue (AT) distribution patient characteristics (BMI and sex steroid levels).
| Relationship between AT distribution and BMI | Patients (n) | VFA/VAV | SFA/SAV | TFA/TAV | V/S ratio | VAT% |
|---|---|---|---|---|---|---|
| Cho | 52 | r2 = 0.299 p ≤ 0.0001 |
r2 = 0.528 p ≤ 0.0001 |
r2 = 0.584 p ≤ 0.0001 |
x | x |
| Wada | 145 | R = 0.678 p ≤ 0.01 |
R = 0.872 p ≤ 0.01 |
R = 0.871 p ≤ 0.01 |
R = 0.05 p = 0.52 |
x |
| Ye | 200 | x | x | R = 0.667 p ≤ 0.0001 |
x | R = 0.743 p = 0.495 |
| Nakamura | 122 | R = 0.743 p ≤ 0.0001 |
R = 0.895 p ≤ 0.0001 |
R = 0.907 p ≤ 0.0001 |
x | x |
| Mauland | 227 | r = 0.78 p ≤ 0.0001 |
r = 0.87 p ≤ 0.0001 |
r = 0.89 p ≤ 0.001 |
x | x |
| Relationship AT distribution and sex steroid levels | Patiënts (n) | VAV | SAV | TAV | BMI | VAV% |
| Tangen | 20 | |||||
| * E2 | r = 0.42 p = 0.068 |
r = 0.005 p = 0.98 |
r = 0.24 p = 0.31 |
x | r = 0.47 p = 0.035 |
|
| Weelden | 39 | |||||
| * E2 | r = 0.58 p ≤ 0.01 |
r = 0.74 p ≤ 0.01 |
r = 0.74 p ≤ 0.01 |
r = 0.62 p ≤ 0.01 |
r = −0.06 NS |
|
| * A4 | r = 0.29 NS |
r = 0.43 p ≤ 0.01 |
r = 0.37 p ≤ 0.05 |
r = 0.26 NS |
r = −0.17 NS |
|
| * DHEAS | r = 0.3 p ≤ 0.05 |
r = 0.3 p ≤ 0.05 |
r = 0.30 NS |
r = 0.36 p ≤ 0.05 |
r = −0.10 NS |
VFA, visceral fat area; VAV, visceral abdominal fat area; SFA, subcutaneous fat area; SAV, subcutaneous abdominal fat area; TFA, total fat area; TAV, total abdominal fat area; VAT%/VAV%, percentage of visceral adipose tissue; A4, androstenedione; DHEAS, dehydroepiandrosteronsulfate; x, outcome not reported; NS, not significant.
Bold values are statistical significant values.